Table of Contents

2019-2024 Global Irritable Bowel Syndrome (IBS) Consumption Market Report

1 Scope of the Report
1.1 Market Introduction
1.2 Research Objectives
1.3 Years Considered
1.4 Market Research Methodology
1.5 Economic Indicators
1.6 Currency Considered

2 Executive Summary
2.1 World Market Overview
2.1.1 Global Irritable Bowel Syndrome (IBS) Consumption 2014-2024
2.1.2 Irritable Bowel Syndrome (IBS) Consumption CAGR by Region
2.2 Irritable Bowel Syndrome (IBS) Segment by Type
2.2.1 IBS-D Drug
2.2.2 IBS-C Drug
2.2.3 Other
2.3 Irritable Bowel Syndrome (IBS) Consumption by Type
2.3.1 Global Irritable Bowel Syndrome (IBS) Consumption Market Share by Type (2014-2019)
2.3.2 Global Irritable Bowel Syndrome (IBS) Revenue and Market Share by Type (2014-2019)
2.3.3 Global Irritable Bowel Syndrome (IBS) Sale Price by Type (2014-2019)
2.4 Irritable Bowel Syndrome (IBS) Segment by Application
2.4.1 Women
2.4.2 Men
2.5 Irritable Bowel Syndrome (IBS) Consumption by Application
2.5.1 Global Irritable Bowel Syndrome (IBS) Consumption Market Share by Application (2014-2019)
2.5.2 Global Irritable Bowel Syndrome (IBS) Value and Market Share by Application (2014-2019)
2.5.3 Global Irritable Bowel Syndrome (IBS) Sale Price by Application (2014-2019)

3 Global Irritable Bowel Syndrome (IBS) by Players
3.1 Global Irritable Bowel Syndrome (IBS) Sales Market Share by Players
3.1.1 Global Irritable Bowel Syndrome (IBS) Sales by Players (2017-2019)
3.1.2 Global Irritable Bowel Syndrome (IBS) Sales Market Share by Players (2017-2019)
3.2 Global Irritable Bowel Syndrome (IBS) Revenue Market Share by Players
3.2.1 Global Irritable Bowel Syndrome (IBS) Revenue by Players (2017-2019)
3.2.2 Global Irritable Bowel Syndrome (IBS) Revenue Market Share by Players (2017-2019)
3.3 Global Irritable Bowel Syndrome (IBS) Sale Price by Players
3.4 Global Irritable Bowel Syndrome (IBS) Manufacturing Base Distribution, Sales Area, Product Types by Players
3.4.1 Global Irritable Bowel Syndrome (IBS) Manufacturing Base Distribution and Sales Area by Players
3.4.2 Players Irritable Bowel Syndrome (IBS) Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) (2017-2019)
3.6 New Products and Potential Entrants
3.7 Mergers and Acquisitions, Expansion

4 Irritable Bowel Syndrome (IBS) by Regions
4.1 Irritable Bowel Syndrome (IBS) by Regions
4.1.1 Global Irritable Bowel Syndrome (IBS) Consumption by Regions
4.1.2 Global Irritable Bowel Syndrome (IBS) Value by Regions
4.2 Americas Irritable Bowel Syndrome (IBS) Consumption Growth
4.3 APAC Irritable Bowel Syndrome (IBS) Consumption Growth
4.4 Europe Irritable Bowel Syndrome (IBS) Consumption Growth
4.5 Middle East and Africa Irritable Bowel Syndrome (IBS) Consumption Growth

5 Americas
5.1 Americas Irritable Bowel Syndrome (IBS) Consumption by Countries
5.1.1 Americas Irritable Bowel Syndrome (IBS) Consumption by Countries (2014-2019)
5.1.2 Americas Irritable Bowel Syndrome (IBS) Value by Countries (2014-2019)
5.2 Americas Irritable Bowel Syndrome (IBS) Consumption by Type
5.3 Americas Irritable Bowel Syndrome (IBS) Consumption by Application
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Key Economic Indicators of Few Americas Countries

6 APAC
6.1 APAC Irritable Bowel Syndrome (IBS) Consumption by Countries
6.1.1 APAC Irritable Bowel Syndrome (IBS) Consumption by Countries (2014-2019)
6.1.2 APAC Irritable Bowel Syndrome (IBS) Value by Countries (2014-2019)
6.2 APAC Irritable Bowel Syndrome (IBS) Consumption by Type
6.3 APAC Irritable Bowel Syndrome (IBS) Consumption by Application
6.4 China
6.5 Japan
6.6 Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 Key Economic Indicators of Few APAC Countries

7 Europe
7.1 Europe Irritable Bowel Syndrome (IBS) by Countries
7.1.1 Europe Irritable Bowel Syndrome (IBS) Consumption by Countries (2014-2019)
7.1.2 Europe Irritable Bowel Syndrome (IBS) Value by Countries (2014-2019)
7.2 Europe Irritable Bowel Syndrome (IBS) Consumption by Type
7.3 Europe Irritable Bowel Syndrome (IBS) Consumption by Application
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
7.9 Spain
7.10 Key Economic Indicators of Few Europe Countries

8 Middle East and Africa
8.1 Middle East and Africa Irritable Bowel Syndrome (IBS) by Countries
8.1.1 Middle East and Africa Irritable Bowel Syndrome (IBS) Consumption by Countries (2014-2019)
8.1.2 Middle East and Africa Irritable Bowel Syndrome (IBS) Value by Countries (2014-2019)
8.2 Middle East and Africa Irritable Bowel Syndrome (IBS) Consumption by Type
8.3 Middle East and Africa Irritable Bowel Syndrome (IBS) Consumption by Application
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries

9 Market Drivers, Challenges and Trends
9.1 Market Drivers and Impact
9.1.1 Growing Demand from Key Regions
9.1.2 Growing Demand from Key Applications and Potential Industries
9.2 Market Challenges and Impact
9.3 Market Trends

10 Marketing, Distributors and Customer
10.1 Sales Channel
10.1.1 Direct Channels
10.1.2 Indirect Channels
10.2 Irritable Bowel Syndrome (IBS) Distributors
10.3 Irritable Bowel Syndrome (IBS) Customer

11 Global Irritable Bowel Syndrome (IBS) Market Forecast
11.1 Global Irritable Bowel Syndrome (IBS) Consumption Forecast (2019-2024)
11.2 Global Irritable Bowel Syndrome (IBS) Forecast by Regions
11.2.1 Global Irritable Bowel Syndrome (IBS) Forecast by Regions (2019-2024)
11.2.2 Global Irritable Bowel Syndrome (IBS) Value Forecast by Regions (2019-2024)
11.2.3 Americas Consumption Forecast
11.2.4 APAC Consumption Forecast
11.2.5 Europe Consumption Forecast
11.2.6 Middle East and Africa Consumption Forecast
11.3 Americas Forecast by Countries
11.3.1 United States Market Forecast
11.3.2 Canada Market Forecast
11.3.3 Mexico Market Forecast
11.3.4 Brazil Market Forecast
11.4 APAC Forecast by Countries
11.4.1 China Market Forecast
11.4.2 Japan Market Forecast
11.4.3 Korea Market Forecast
11.4.4 Southeast Asia Market Forecast
11.4.5 India Market Forecast
11.4.6 Australia Market Forecast
11.5 Europe Forecast by Countries
11.5.1 Germany Market Forecast
11.5.2 France Market Forecast
11.5.3 UK Market Forecast
11.5.4 Italy Market Forecast
11.5.5 Russia Market Forecast
11.5.6 Spain Market Forecast
11.6 Middle East and Africa Forecast by Countries
11.6.1 Egypt Market Forecast
11.6.2 South Africa Market Forecast
11.6.3 Israel Market Forecast
11.6.4 Turkey Market Forecast
11.6.5 GCC Countries Market Forecast
11.7 Global Irritable Bowel Syndrome (IBS) Forecast by Type
11.8 Global Irritable Bowel Syndrome (IBS) Forecast by Application

12 Key Players Analysis
12.1 Allergan
12.1.1 Company Details
12.1.2 Irritable Bowel Syndrome (IBS) Product Offered
12.1.3 Allergan Irritable Bowel Syndrome (IBS) Sales, Revenue, Price and Gross Margin (2017-2019)
12.1.4 Main Business Overview
12.1.5 Allergan News
12.2 Valeant Pharmaceuticals
12.2.1 Company Details
12.2.2 Irritable Bowel Syndrome (IBS) Product Offered
12.2.3 Valeant Pharmaceuticals Irritable Bowel Syndrome (IBS) Sales, Revenue, Price and Gross Margin (2017-2019)
12.2.4 Main Business Overview
12.2.5 Valeant Pharmaceuticals News
12.3 Takeda
12.3.1 Company Details
12.3.2 Irritable Bowel Syndrome (IBS) Product Offered
12.3.3 Takeda Irritable Bowel Syndrome (IBS) Sales, Revenue, Price and Gross Margin (2017-2019)
12.3.4 Main Business Overview
12.3.5 Takeda News
12.4 Sucampo Pharmaceuticals
12.4.1 Company Details
12.4.2 Irritable Bowel Syndrome (IBS) Product Offered
12.4.3 Sucampo Pharmaceuticals Irritable Bowel Syndrome (IBS) Sales, Revenue, Price and Gross Margin (2017-2019)
12.4.4 Main Business Overview
12.4.5 Sucampo Pharmaceuticals News
12.5 McNeil Consumer Healthcare
12.5.1 Company Details
12.5.2 Irritable Bowel Syndrome (IBS) Product Offered
12.5.3 McNeil Consumer Healthcare Irritable Bowel Syndrome (IBS) Sales, Revenue, Price and Gross Margin (2017-2019)
12.5.4 Main Business Overview
12.5.5 McNeil Consumer Healthcare News
12.6 Sebela Pharmaceuticals
12.6.1 Company Details
12.6.2 Irritable Bowel Syndrome (IBS) Product Offered
12.6.3 Sebela Pharmaceuticals Irritable Bowel Syndrome (IBS) Sales, Revenue, Price and Gross Margin (2017-2019)
12.6.4 Main Business Overview
12.6.5 Sebela Pharmaceuticals News
12.7 Astellas Pharmaceuticals
12.7.1 Company Details
12.7.2 Irritable Bowel Syndrome (IBS) Product Offered
12.7.3 Astellas Pharmaceuticals Irritable Bowel Syndrome (IBS) Sales, Revenue, Price and Gross Margin (2017-2019)
12.7.4 Main Business Overview
12.7.5 Astellas Pharmaceuticals News
12.8 IM HealthScience
12.8.1 Company Details
12.8.2 Irritable Bowel Syndrome (IBS) Product Offered
12.8.3 IM HealthScience Irritable Bowel Syndrome (IBS) Sales, Revenue, Price and Gross Margin (2017-2019)
12.8.4 Main Business Overview
12.8.5 IM HealthScience News

13 Research Findings and Conclusion